Loading...
•
Mar 31, 2020
Pediatrix Q1 2020 Earnings Report
Reported a loss from continuing operations due to the impact of COVID-19 and sale of American Anesthesiology.
Key Takeaways
MEDNAX reported a challenging first quarter, marked by a net revenue of $846 million but a loss of $16 million. The company's performance was significantly impacted by the COVID-19 pandemic, which reduced consolidated revenue by approximately $40 million compared to forecasted revenue. Additionally, MEDNAX completed the sale of American Anesthesiology subsequent to the end of the quarter.
Net revenue for the quarter was $846 million.
Loss from continuing operations was $16 million, or $0.20 per share.
Adjusted EPS from continuing operations was $0.32.
Adjusted EBITDA from continuing operations was $63 million.
Forward Guidance
Due to the rapidly evolving environment and continued uncertainties surrounding the impact of COVID-19, the Company is not providing any outlook for its performance for the second quarter of 2020 or for the full year 2020.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...